Clinical Trials
24 trialsSERENTA
Rapamycin Holdings Inc.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
Hospices Civils de Lyon
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
RAPA-4-PAF
University Hospital, Toulouse
iCaRe2
University of Nebraska
VitB1; FAP
Shanghai Zhongshan Hospital
SJFAMILY
St. Jude Children's Research Hospital
TUPELO
Recursion Pharmaceuticals Inc.
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NuView
Vanderbilt University Medical Center
LATA-IBD
Sahlgrenska University Hospital
RESTODIG
Assistance Publique Hopitaux De Marseille
DRACO
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
BHB-FAP
Abramson Cancer Center at Penn Medicine
Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
Instituto do Cancer do Estado de São Paulo
TESTIMONY
Odense University Hospital
Papillectomy
Azienda USL Reggio Emilia - IRCCS